PATENT CLAIM ANALYSIS

Application Number: 15894842
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["435", "366000"]

Abstract:
This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.

Claim (Index 24):
The method of  claim 21 , wherein the concentration of bFGF is about 80 ng/mL.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.3617
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11917993', '10235094', '12763884', '12170219', '13323567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.67503196187538
- 35 USC 102 Novelty (BERT): 0.5462438578219502
- Combined Prediction Score: 0.662153151470037
- Mean Citation Score: 403.00106000000005
- Max Citation Score: 439.70462
- Similarity Product: 283.8941475633931

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test